Cytiva's Whatman™ 17-3715-01 Capto™ Adhere ImpRes Multimodal Chromatography Resin, 25mL
- Ligand: Multimodal strong anion exchanger, Matrix: High-flow agarose
- Particle size, d50V1: ~40 μm, BioProcess resin: Yes, Ionic Capacity: 0.08-0.11mmol Cl-/mL medium
- pH Stability-operational2: 3–12, pH Stability-CIP3: 2–14, Pressure/Flow Specification: 300kPa
- Storage: 4°C to 30°C in 20% ethanol, Binding Capacity/mL Chromatography Medium: 45-85mg mab/mL
- Avoid Using: Oxidizing agents, anionic detergents, Certificate of Analysis: Yes
- Sold Individually
- Manufacturer Part No: WHA-17-3715-01
PLEASE NOTE: Product images and descriptions may not exactly represent the product. Prior to making your purchase, please confirm that the manufacturer part number shown above matches the product you seek. Returns are not allowed for such differences if the correct manufacturer part number is shipped.
Details
Chemical stability: Commonly used aqueous buffers, 1 M acetic acid, 1 M NaOH, 2 M NaCl, 5% 1-propanol, 30% isopropanol, 70% ethanol This multimodal, strong anion exchange resin supports effective mAb polishing in the second or third step of a purification scheme downstream of the protein A capture step. High yields achieved through the high-resolution beads and selectivity of the ligand. Efficient removal of aggregates, viruses, and main contaminants in mAb processes. Enables use of a platform approach to mAb process development. Allows separation of mAb charged variants. Resin fulfills industrial demands for security of supply, robust performance, and regulatory support
Documents & Videos
Chemical stability: Commonly used aqueous buffers, 1 M acetic acid, 1 M NaOH, 2 M NaCl, 5% 1-propanol, 30% isopropanol, 70% ethanol This multimodal, strong anion exchange resin supports effective mAb polishing in the second or third step of a purification scheme downstream of the protein A capture step. High yields achieved through the high-resolution beads and selectivity of the ligand. Efficient removal of aggregates, viruses, and main contaminants in mAb processes. Enables use of a platform approach to mAb process development. Allows separation of mAb charged variants. Resin fulfills industrial demands for security of supply, robust performance, and regulatory support